Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts Cardano Price Forecast: Can ADA Price Rebound on Renewed Whale Demand? January 27, 2026 Verge (XVG) Price Prediction 2026, 2027 – 2030, Can Privacy Coins Regain Relevance? January 27, 2026 BlackRock Files Bitcoin Income ETF as Institutions Shift Strategy January 27, 2026